跳至主要内容
临床试验/ITMCTR2200005909
ITMCTR2200005909尚未招募1 期

Study on the mechanism of Qingchangxiaopi Decoction and UC large intestine damp-heat syndrome from the activation of LPDC through TLR5-IRF4 pathway to mediate intestinal inflammation

Dongguan Hospital of Guangzhou University of Chinese Medinine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 70(—)
性别
Male

入选标准

  • ?The healthy subjects were inquired about medical history and physical examination, excluded cardiovascular and cerebrovascular diseases, diabetes, hypertension, hyperlipidemia and other medical history, and excluded intestinal organic diseases.
  • ?UC patients who meet the diagnostic criteria;
  • ?Meet the criteria for UC in the light to moderate activity period;
  • ?Those who signed the informed consent.

排除标准

  • ?Patients with severe heart, liver, kidney and other major organ diseases, hematopoietic system, nervous system or mental diseases;
  • ?Patients with serious complications such as local stricture, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal disease;
  • ?Reluctance to sign informed consent and collaborators.

研究者

发起方
Dongguan Hospital of Guangzhou University of Chinese Medinine

相似试验